The city’s proposed pharmaceutical licensing fee included in the 2017 budget appears to be focused more on tracking drug marketers than revenue. As detailed in the 2017 Management Ordinance introduced this week, the application process would require a significant amount of information aimed at tracking the doctors pharmaceutical reps are meeting with and what drugs they’re pushing.

Want to read the whole article?

Members of The Daily Line get full access to articles associated with their subscription, including our archives, spreadsheets, and reports, along with our daily newsletters and exclusive offers on our special events.

Sign up